Fineotex Chemical Limited — PPTs, 21-05-2025: Investor Presentation

1. Financial Highlights:

Fineotex reported revenue of Rs. 533.33 Cr for FY25, down 4.76% YoY, signaling mild demand softness. EBITDA declined 14.26% to Rs. 127.23 Cr, with margins contracting 222 bps to 23.85%. Profit after tax stood at Rs. 109.21 Cr, down 9.76%, with PAT margin at 20.48%. Q4 saw sharper declines with revenues of Rs. 119.79 Cr (-18.98% YoY) and PAT of Rs. 20.13 Cr (-33.94%). Gross margins held steady near 38.5%, but volume softness affected profitability. The balance sheet strengthened materially, with total assets rising to Rs. 815 Cr from Rs. 555 Cr, driven by property and equity infusion, boosting net worth to Rs. 739 Cr. Working capital days improved to 81 from 65, indicating better asset management.

2. Strategic Initiatives & Growth Drivers:

Fineotex is expanding capacity with a 15,000 MTPA greenfield plant at Ambernath expected by Q2FY26, raising total capacity to 1,20,000 MTPA. The company advances sustainability with 15 new products and 25 new customers added in Q4. Growth focus intensifies beyond textile chemicals, scaling Water Treatment and Oil & Gas verticals through capex and innovation. The biotech AquaStrike Premium mosquito-control solution, with multiple international approvals, opens new public health markets. Favorable trade agreements like India-UK FTA may boost export potential.

3. Business Developments:

Fineotex strengthened partnerships with HealthGuard (Australia) for antimicrobials and EuroDye-CTC (Belgium) for specialty chemicals commercialization in India. It enhanced R&D collaboration with Sasmira Institute for sustainable chemistry innovation. Acquisition of 7 acres at Ambernath supports capacity expansion. Its international footprint spans 70 countries, and inorganic growth remains a key focus alongside organic initiatives.

4. Market Position & Competitive Advantage:

A leader in specialty chemicals, Fineotex offers 470+ products across textiles, FMCG cleaning & hygiene, water treatment, and oil & gas sectors. Its diversified manufacturing bases, certified with GMP, FDA, Bluesign, ZDHC and NABL, enable customized, sustainable solutions. Deep customer ties, strong technical expertise, and a debt-free balance sheet generate financial flexibility and competitive edge.

5. Investor Implications:

Fineotex’s diversified portfolio, capacity expansion, and sustainability-driven growth point to positive growth potential, especially in water treatment and oil & gas chemicals. Recent margin pressure and top-line softness highlight execution risks to monitor on demand and product mix evolution. Strategic collaborations and new product launches provide innovation levers. Overall, Fineotex presents a stable specialty chemicals platform with long-term growth supported by global reach and greenfield capacity additions.